Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers

BACKGROUND: People with HIV (PWH) have increased cardiovascular events, inflammation, and high-risk coronary atherosclerosis. Statin therapy has been shown to lower the risk of cardiovascular disease (CVD) in the general population, but whether this results from reductions in coronary atherosclerosi...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Am Heart J
المؤلفون الرئيسيون: Hoffmann, Udo, Lu, Michael T., Olalere, Devvora, Adami, Elizabeth C., Osborne, Michael T., Ivanov, Alex, Sukumar Aluru, John, Lee, Saeyun, Arifovic, Nadja, Turner Overton, Edgar, Fichtenbaum, Carl J., Aberg, Judith A., Alston-Smith, Beverly, Klingman, Karin L., Waclawiw, Myron, Burdo, Tricia H., Williams, Kenneth C., Zanni, Markella V., Desvigne-Nickens, Patrice, Cooper-Arnold, Katharine, Fitch, Kathleen V., Ribaudo, Heather, Douglas, Pamela S., Grinspoon, Steven K.
التنسيق: Artigo
اللغة:Inglês
منشور في: 2019
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6596304/
https://ncbi.nlm.nih.gov/pubmed/30928823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2019.02.011
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة